Clinical Trial Update: Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing MB12 to pembrolizumab (Keytruda) in stage IV non-small cell lung cancer is currently recruiting to evaluate PK, efficacy, safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• MB12

Snippet

Sponsor: Laboratorio Elea Phoenix S.A. | Conditions: Non Small Cell Lung Cancer Metastatic | Phase 3 | Status: RECRUITING